Jean-Guillaume Dillinger Selected Research

Body Weight (Weight, Body)

2/2018

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Guillaume Dillinger Research Topics

Disease

6	Acute Coronary Syndrome 01/2022 - 10/2012
5	Hemorrhage 10/2021 - 01/2018
4	ST Elevation Myocardial Infarction 10/2021 - 01/2016
4	Myocardial Infarction 01/2021 - 04/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2011
3	Thrombosis (Thrombus) 04/2019 - 12/2013
3	Out-of-Hospital Cardiac Arrest 01/2016 - 04/2012
2	Diabetes Mellitus 05/2022 - 05/2015
2	Necrosis 11/2020 - 04/2019
2	Heart Arrest (Cardiac Arrest) 06/2018 - 01/2018
2	Coma (Comas) 01/2016 - 04/2012
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Unstable Angina 10/2021
1	Vascular System Injuries 01/2021
1	Neoplasms (Cancer) 12/2018
1	Ventricular Fibrillation 06/2018
1	Shock 06/2018
1	Stroke (Strokes) 02/2018
1	Thromboembolism 02/2018
1	Body Weight (Weight, Body) 02/2018
1	Embolism (Embolus) 02/2018
1	Atrial Fibrillation 02/2018
1	Venous Thromboembolism 01/2018
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Thrombophilia 01/2018
1	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2015
1	Essential Thrombocythemia 01/2012

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2016 - 02/2011
5	Biological ProductsIBA 01/2018 - 02/2011
4	TicagrelorIBA 10/2021 - 09/2014
3	Clopidogrel (Plavix)FDA Link 10/2021 - 01/2020
3	AnticoagulantsIBA 12/2018 - 01/2018
2	Prasugrel Hydrochloride FDA Link 10/2021 - 09/2014
2	Troleandomycin (TAO)FDA Link 01/2021 - 01/2018
2	Eptifibatide (Integrilin)FDA Link 01/2021 - 01/2018
2	otamixabanIBA 01/2021 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2018
2	AntithrombinsIBA 04/2019 - 01/2018
1	Insulin (Novolin)FDA Link 05/2022
1	CalciumIBA 01/2022
1	AntibodiesIBA 01/2021
1	Troponin T (Troponin T1)IBA 04/2019
1	Thrombin FDA Link 04/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2018
1	CatecholaminesIBA 06/2018
1	RivaroxabanIBA 02/2018
1	Pharmaceutical PreparationsIBA 02/2018
1	apixabanIBA 02/2018
1	N(4)-oleylcytosine arabinosideIBA 02/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	factor V LeidenIBA 01/2018
1	Prothrombin (Factor II)IBA 01/2018
1	Protein CIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	IvabradineIBA 12/2015
1	SolutionsIBA 06/2015
1	Fibrinogen (Factor I)FDA Link 05/2015
1	von Willebrand FactorIBA 05/2015
1	Arachidonic Acid (Vitamin F)IBA 05/2015
1	TroponinIBA 04/2012

Therapy/Procedure

6	Percutaneous Coronary Intervention 01/2021 - 10/2012
3	Stents 01/2020 - 12/2013
2	Cardiopulmonary Resuscitation (CPR) 06/2018 - 04/2012
2	Extracorporeal Membrane Oxygenation 06/2018 - 01/2018
1	Drug Therapy (Chemotherapy) 12/2018
1	Polypharmacy 02/2018
1	Induced Hypothermia 01/2016
1	Therapeutics 12/2015
1	Secondary Prevention 05/2015